JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB221680

Anti-uPA Receptor/U-PAR antibody [EPR22173-257]

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Recombinant Monoclonal uPA Receptor/U-PAR antibody. Suitable for IP, Flow Cyt, ICC/IF and reacts with Human samples. Cited in 5 publications.

View Alternative Names

CD87, MO3, UPAR, PLAUR, Urokinase plasminogen activator surface receptor, U-PAR, uPAR, Monocyte activation antigen Mo3

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (AB221680)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (AB221680)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized U937 (human histiocytic lymphoma cell line) cells, untreated or treated with TPA (200 nM, 72 hours), labeling uPA Receptor/U-PAR with ab221680 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing membranous staining in U937 cells treated with TPA (200 nM, 72 hours).

The expression of uPA Receptor/U-PAR is induced in PMA-stimulated U937 cells (PMID : 24999729).

The nuclear counterstain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Flow Cytometry - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (AB221680)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (AB221680)

Flow cytometric analysis of U937 (human histiocytic lymphoma cell line) cell line treated with 200 nM TPA for 72 hours (red) or Untreated control (green) labeling uPA Receptor/U-PAR with ab221680 at 1/500 dilution compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

The expression of uPA Receptor/U-PAR is induced in PMA-stimulated U937 cells (PMID : 24999729)

Immunoprecipitation - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (AB221680)
  • IP

Unknown

Immunoprecipitation - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (AB221680)

uPA Receptor/U-PAR was immunoprecipitated from 0.35 mg of U937 (human histiocytic lymphoma cell line) treated with 200 nM TPA for 72 hours whole cell lysate with ab221680 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab221680 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.

Lane 1 : U937 treated with 200 nM TPA for 72 hours whole cell lysate 10 μg (Input).

Lane 2 : ab221680 IP in U937 treated with 200 nM TPA for 72 hours whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab221680 in U937 treated with 200 nM TPA for 72 hours whole cell lysate.

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : 30 seconds.

The expression of uPA Receptor/U-PAR is induced in PMA-stimulated U937 cells and the molecular weight is consistent with what has been described in the literature (PMID : 24999729).

All lanes:

Immunoprecipitation - Anti-uPA Receptor/U-PAR antibody [EPR22173-257] (ab221680)

Predicted band size: 37 kDa

false

  • Carrier free

    Anti-uPA Receptor/U-PAR antibody [EPR22173-257] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22173-257

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, Flow Cyt, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as a receptor for urokinase plasminogen activator (PubMed : 15677461). Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form.
See full target information PLAUR

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:25065 PubMed40645977

2025

Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC.

Applications

Unspecified application

Species

Unspecified reactive species

Shouge Zang,Hongwei Chen,Yuqian Han,Di Cui,Jiangtao Yu

International journal of molecular sciences 26: PubMed40508119

2025

N-Glycosylation as a Key Requirement for the Positive Interaction of Integrin and uPAR in Glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Gretel Magalí Ferreira,Hector Adrian Cuello,Aylen Camila Nogueira,Jeremias Omar Castillo,Selene Rojo,Cynthia Antonella Gulino,Valeria Inés Segatori,Mariano Rolando Gabri

Biomarker research 12:113 PubMed39334513

2024

Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Jiang,Chao Xu,Donghui Han,Yuan Lu,Fa Yang,Jiawei Wang,Xiaolong Yan,Xiaorong Mu,Jipeng Zhang,Chenghui Jia,Xinyao Xu,Kui Liu,Zhenhua Liu,Li Gong,Yi Wan,Qiang Lu

Translational neurodegeneration 13:1 PubMed38173017

2024

Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Min Zhang,Zhan Zhang,Honghong Li,Yuting Xia,Mengdan Xing,Chuan Xiao,Wenbao Cai,Lulu Bu,Yi Li,Tae-Eun Park,Yamei Tang,Xiaojing Ye,Wei-Jye Lin

Frontiers in immunology 13:845956 PubMed35371006

2022

The uPA System Differentially Alters Fibroblast Fate and Profibrotic Ability in Skin Fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Li Zou,Ying-Ying Teng,Zhong-Hua Chen,Si-Yu Liu,Yuan Jia,Kai-Wen Zhang,Jun-Jie Wu,Zheng-Dong Yuan,Xiao-Yu Tang,Shun Yu,Jun-Xing Ye,Xia Li,Xiao-Jin Zhou,Feng-Lai Yuan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com